v3.26.3
Weighted Average Shares Outstanding (Details) - shares
shares in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]        
Basic weighted average common shares outstanding 162,758 162,305 162,587 162,137
Dilutive effect of equity awards 542 342 657 400
Diluted weighted average common shares outstanding 163,300 162,647 163,244 162,537
Anti-dilutive shares excluded from diluted earnings per share 18,927 751 18,844 727
Share-Based Payment Arrangement        
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]        
Anti-dilutive shares excluded from diluted earnings per share [1] 202 751 119 727
Convertible Debt Securities        
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]        
Anti-dilutive shares excluded from diluted earnings per share [2] 18,725 0 18,725 0
[1] Shares were excluded from the dilutive-effect calculation because the outstanding awards' exercise prices were greater than the average market price of the Company's common stock for the periods presented.
[2] The anti-dilutive impact of the 2031 Notes is based on the full conversion of the outstanding principal of the 2031 Notes. The principal portion of the 2031 Notes is required to be settled in cash. The 2026 Capped Calls are expected to reduce the potential dilution to the Company’s common stock (or, in the event a conversion of the 2031 Notes was settled in cash, to reduce the cash payment obligation) in the event that at the time of conversion of the 2031 Notes the Company’s common stock price exceeded the conversion price of the 2031 Notes.